Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 56, 3711-3715, August 15, 1996]
© 1996 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suganuma, M.
Right arrow Articles by Fujiki, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suganuma, M.
Right arrow Articles by Fujiki, H.

A New Process of Cancer Prevention Mediated through Inhibition of Tumor Necrosis Factor {alpha} Expression1

Masami Suganuma, Sachiko Okabe, Eisaburo Sueoka, Naoyuki Iida2, Atsumasa Komori, Seong-Jin Kim and Hirota Fujiki3

Saitama Cancer Center Research Institute, Ina, Kitaadachi-gun, Saitama 362, Japan [M. S., S. O., E. S., N. I., A. K., H. F.]. and Laboratory of Chemoprevention, National Cancer Institute, Bethesda, Maryland 20892 [S-J. K.]

Mechanisms of cancer prevention were studied using structurally different cancer-preventive agents, sarcophytol A, canventol, (-)-epigallocatechin gallate, and tamoxifen, based on our evidence that tumor necrosis factor {alpha} (TNF-{alpha}) acts as an endogenous tumor promoter relevant to human carcinogenesis. Pretreatment with the four preventive agents commonly inhibited TNF-{alpha} mRNA expression and TNF-{alpha} release in BALB/3T3 cells induced by a tumor promoter, okadaic acid, whereas the expression of early response genes (c-jun, junB, c-fos, and fosB) was enhanced. These results strongly suggest that inhibition of TNF-{alpha} mRNA expression and its release is a new process of cancer prevention.

1 This work was supported in part by Grants-in-Aid for Cancer Research from the Ministry of Health and Welfare for a Second-Term Comprehensive 10-Year Strategy for Cancer Control, a grant from the Ministry of Health and Welfare, a grant from Monbusho International Scientific Research Program, Special Cancer Research from the Ministry of Education, Science and Culture, Japan, and grants from the Foundation of Promotion of Cancer Research, the Princess Takamatsu Cancer Research Fund, the Smoking Research Fund, the Uehara Memorial Life Science Foundation, MOA Health Science Foundation, Suzuken Memorial Foundation, the Asahi Glass Foundation, and the Plant Science Research Foundation of the Faculty of Agriculture Kyoto University.

2 Present address: Faculty of Pharmaceutical Sciences, Science University of Tokyo, Tokyo 162, Japan.

3 To whom requests for reprints should be addressed.

Received 3/11/96. Accepted 6/17/96.




This article has been cited by other articles:


Home page
Integr Cancer TherHome page
G. Deep and R. Agarwal
Chemopreventive Efficacy of Silymarin in Skin and Prostate Cancer
Integr Cancer Ther, June 1, 2007; 6(2): 130 - 145.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
T. Kuzuhara, Y. Sei, K. Yamaguchi, M. Suganuma, and H. Fujiki
DNA and RNA as New Binding Targets of Green Tea Catechins
J. Biol. Chem., June 23, 2006; 281(25): 17446 - 17456.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. J. Fabian, B. F. Kimler, J. Anderson, O. W. Tawfik, M. S. Mayo, W. E. Burak Jr., J. A. O'Shaughnessy, K. S. Albain, D. M. Hyams, G. T. Budd, et al.
Breast Cancer Chemoprevention Phase I Evaluation of Biomarker Modulation by Arzoxifene, a Third Generation Selective Estrogen Receptor Modulator
Clin. Cancer Res., August 15, 2004; 10(16): 5403 - 5417.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Takada and B. B. Aggarwal
Betulinic Acid Suppresses Carcinogen-Induced NF-{kappa}B Activation Through Inhibition of I{kappa}B{alpha} Kinase and p65 Phosphorylation: Abrogation of Cyclooxygenase-2 and Matrix Metalloprotease-9
J. Immunol., September 15, 2003; 171(6): 3278 - 3286.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Shishodia, S. Majumdar, S. Banerjee, and B. B. Aggarwal
Ursolic Acid Inhibits Nuclear Factor-{kappa}B Activation Induced by Carcinogenic Agents through Suppression of I{kappa}B{alpha} Kinase and p65 Phosphorylation: Correlation with Down-Regulation of Cyclooxygenase 2, Matrix Metalloproteinase 9, and Cyclin D1
Cancer Res., August 1, 2003; 63(15): 4375 - 4383.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Suganuma, M. Kurusu, S. Okabe, N. Sueoka, M. Yoshida, Y. Wakatsuki, and H. Fujiki
Helicobacter Pylori Membrane Protein 1: A New Carcinogenic Factor of Helicobacter Pylori
Cancer Res., September 1, 2001; 61(17): 6356 - 6359.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
K. M.W. Pisters, R. A. Newman, B. Coldman, D. M. Shin, F. R. Khuri, W. K. Hong, B. S. Glisson, and J. S. Lee
Phase I Trial of Oral Green Tea Extract in Adult Patients With Solid Tumors
J. Clin. Oncol., March 15, 2001; 19(6): 1830 - 1838.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. Sai, J. Kanno, R. Hasegawa, J. E. Trosko, and T. Inoue
Prevention of the down-regulation of gap junctional intercellular communication by green tea in the liver of mice fed pentachlorophenol
Carcinogenesis, September 1, 2000; 21(9): 1671 - 1676.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. S. Yang, J. Y. Chung, G.-y. Yang, S. K. Chhabra, and M.-J. Lee
Tea and Tea Polyphenols in Cancer Prevention
J. Nutr., February 1, 2000; 130(2): 472 - 472.
[Abstract] [Full Text]


Home page
Exp. Biol. Med.Home page
M. W. Pariza, Y. Park, and M. E. Cook
Mechanisms of Action of Conjugated Linoleic Acid: Evidence and Speculation
Experimental Biology and Medicine, January 1, 2000; 223(1): 8 - 13.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
M. Suganuma, S. Okabe, M. W. Marino, A. Sakai, E. Sueoka, and H. Fujiki
Essential Role of Tumor Necrosis Factor {{alpha}} (TNF-{{alpha}}) in Tumor Promotion as Revealed by TNF-{{alpha}}-deficient Mice
Cancer Res., September 1, 1999; 59(18): 4516 - 4518.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
K. Mabe, M. Yamada, I. Oguni, and T. Takahashi
In Vitro and In Vivo Activities of Tea Catechins against Helicobacter pylori
Antimicrob. Agents Chemother., July 1, 1999; 43(7): 1788 - 1791.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
M. Suganuma, S. Okabe, Y. Kai, N. Sueoka, E. Sueoka, and H. Fujiki
Synergistic Effects of (-)-Epigallocatechin Gallate with (-)-Epicatechin, Sulindac, or Tamoxifen on Cancer-preventive Activity in the Human Lung CancerCell Line PC-9
Cancer Res., January 1, 1999; 59(1): 44 - 47.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Balasubramanian, T. Efimova, and R. L. Eckert
Green Tea Polyphenol Stimulates a Ras, MEKK1, MEK3, and p38 Cascade to Increase Activator Protein 1 Factor-dependent Involucrin Gene Expression in Normal Human Keratinocytes
J. Biol. Chem., January 11, 2002; 277(3): 1828 - 1836.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.